Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRK1 | P41145 | 9/20 | 0.53 |
| ▸ | OPRM1 | P35372 | 8/20 | 0.53 |
| ▸ | OPRD1 | P41143 | 8/20 | 0.53 |
| ▸ | PARP10 | Q53GL7 | 8/20 | 0.50 |
| ▸ | PARP14 | Q460N5 | 4/20 | 0.47 |
| ▸ | PARP15 | Q460N3 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21628783 | 1.00 | OPRK1 (0.53) | OPRK1OPRM1OPRD1PARP10PARP14 | |
| SCHEMBL21628791 | 0.99 | OPRK1 (0.54) | OPRK1OPRM1OPRD1PARP10PARP14 | |
| SCHEMBL21628903 | 0.96 | OPRK1 (0.54) | OPRK1OPRM1OPRD1PARP10PARP14 | |
| SCHEMBL21628819 | 0.94 | PARP10 (0.54) | OPRK1OPRM1OPRD1PARP10PARP14 | |
| SCHEMBL21628714 | 0.89 | KMO (0.49) | OPRK1OPRM1OPRD1ALDH1A1MAPT | |
| SCHEMBL21628462 | 0.89 | KMO (0.49) | OPRK1OPRM1OPRD1ALDH1A1MAPT | |
| SCHEMBL21628681 | 0.87 | LMNA (0.49) | OPRK1OPRM1OPRD1PARP10ALDH1A1 | |
| SCHEMBL21628785 | 0.85 | HDAC6 (0.58) | OPRK1OPRM1OPRD1 | |
| SCHEMBL21628529 | 0.85 | ALDH1A1 (0.47) | OPRK1OPRM1OPRD1ALDH1A1MAPT | |
| SCHEMBL21628394 | 0.85 | LMNA (0.49) | OPRK1OPRM1OPRD1PARP10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12600696-B2 | Aromatic compounds | Xeniopro GmbH (DE) | 2026-04-14 | — | — | US | disclosed |
| US-20230406814-A2 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2023-12-21 | — | — | US | disclosed |
| US-20230150923-A1 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2023-05-18 | — | — | US | disclosed |
| US-11591289-B2 | Aromatic compounds | Xeniopro GmbH (DE) | 2023-02-28 | — | — | US | disclosed |
| US-11591289-B2 | Aromatic compounds | Xeniopro GmbH (DE) | 2023-02-28 | — | — | US | disclosed |
| US-20220348535-A2 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2022-11-03 | — | — | US | disclosed |
| US-20210107863-A2 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2021-04-15 | — | — | US | disclosed |
| US-20200031763-A1 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2020-01-30 | — | — | US | disclosed |
| US-20200031763-A1 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2020-01-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230150923-A1 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | OPRK1 2780/4885OPRM1 3978/4885OPRD1 2899/4885 |
| US-20220348535-A2 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | OPRK1 2780/4885OPRM1 3978/4885OPRD1 2899/4885 |
| US-11591289-B2 | Aromatic compounds | AHR, TYR, MUSK | OPRK1 3124/4885OPRM1 4075/4885OPRD1 3247/4885 |
| US-20210107863-A2 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | OPRK1 2780/4885OPRM1 3978/4885OPRD1 2899/4885 |
| US-12600696-B2 | Aromatic compounds | CCR1, CCRL2, AHR | OPRK1 684/4885OPRM1 817/4885OPRD1 706/4885 |
| US-20230406814-A2 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | OPRK1 2780/4885OPRM1 3978/4885OPRD1 2899/4885 |
| US-20200031763-A1 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | OPRK1 2780/4885OPRM1 3978/4885OPRD1 2899/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.